CSF1 and neoplasm: CSF-1 receptor (CSF-1R) signaling is currently under investigation as a therapeutic target [12, 13] and we have identified CSF-1-stimulated macrophage motility, through PI3K p110δ and SFKs, as a promising specific target to prevent tumor invasion [14-16].